论文信息 - Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir. - 字舞流文

Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir.

K. Ruxrungtham | W. Prasithsirikul | W. Manosuthi | S. Sungkanuparph | N. Chumpathat | Chatiya Athichathanabadi | A. Chaovavanich | W. Tantisiriwat | C. Bowonwatanuwong